Digital First Scientific Communications – How Digital is Transforming Medical Communications EPISODE 1: Compliance in Medical Communications: Struggles and Successes
Elevate Medical Affairs Podcast Channel
00:00
Introduction
Jeff Clemens is the Senior Director for Publication Strategy and Launch at Eli Lilly Company. Jeff: In publications, we generally don't have the same level of external regulations and good practices that exist in the regulatory side of the bio-pharmaceutical business. All company-sponsored trials should be considered for publication, whether they're considered to be positive or negative. At a minimum, all phase three clinical trial results should actually be submitted for publication.
Transcript
Play full episode
